Serum Institute gets DCGI nod to resume clinical trial of AstraZeneca vaccine - Android

Get it on Google Play

Serum Institute gets DCGI nod to resume clinical trial of AstraZeneca vaccine - Android

New Delhi, Sep 16: Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order

16/09/2020 08:15 AM